Aelis Farma’s Phase 2B Study on AEF0117: A New Hope for Cannabis Use Disorder
Aelis Farma, a clinical-stage biopharmaceutical company, has announced the results of its Phase 2B clinical trial for AEF0117, a promising treatment for Cannabis Use Disorder (CUD). The study aimed to…